GoKawiilHHS Tells FDA Not to Block Sales of Six Unapproved Peptide Drugs
HHS Secretary Robert F. Kennedy Jr. has directed the FDA to refrain from taking enforcement action against pharmacies selling six compounded peptides, including BPC-157, KPV and TB-500. The Associated Press reports the decision was made without input from FDA scientists, who generally opposed the change, and HHS says it is intended to expand patient choice while maintaining safety.